Assembly biosciences to present during the svb leerink 11th annual global healthcare conference

South san francisco, calif., feb. 09, 2022 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis b virus (hbv) and other viral diseases, today announced that john mchutchison, ao, md, chief executive officer and president, will participate in a virtual fireside chat during the svb leerink 11th annual global healthcare conference on thursday, february 17, 2022 at 3:40 p.m. et.
ASMB Ratings Summary
ASMB Quant Ranking